Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Mesoblast Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

29 Aug 2015 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Mesoblast Ltd (MSB-AU)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

31 Aug 2015 Thomson Reuters Stock Report 11 $25.00

Wright Investors Service Comprehensive Report for Mesoblast Ltd

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

28 Aug 2015 Wright Reports 55 $75.00

ValuEngine Industry Report for Medical-Biomed/Genetics(MBLTY)

Advanced academic research that brings you superior investment strategies in an actionable format. Industry Analysis Report, ...

26 Aug 2015 ValuEngine, Inc. 10 $49.00

Mesoblast Limited (MSB) - Financial Analysis Review

Mesoblast Limited (MSB) - Financial Analysis Review Summary Mesoblast Limited (Mesoblast) is a biotechnology company. T...

21 Aug 2015 GlobalData 40 $125.00

Mesoblast Limited

Mesoblast Limited is a world leader in the development of biologic products for the broad field of regenerative medicine. Th...

19 Aug 2015 Acquisdata 11 $15.00

Mesoblast Limited - Financial Year 2015 Full Year Results

17 Aug 2015 irasia.com 19 $219.00

Mesoblast Limited - Financial Report for the Year Ended 30 June 2015

17 Aug 2015 irasia.com 109 $1,254.00

Mesoblast Limited - Mesoblast Reports 2015 Financial Year Results and Provides Update on Phase 3 Chronic Heart Failure Program

17 Aug 2015 irasia.com 3 $35.00

Mesoblast Limited - Appendix 4E - Preliminary Final Report for the Twelve Months to 30 June 2015

17 Aug 2015 irasia.com 2 $23.00